VEGFA and breast carcinoma: Compared with healthy controls, the ratio of plasma VEGF-A165b to VEGF-A was significantly lower in breast cancer patients before the initiation of chemotherapy (p = 0.0026 (BS1)) and at the blood sample after completion of chemotherapy (p = 0.0004 (BS2).